{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:14:04Z","timestamp":1764594844931,"version":"3.46.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR Academic Clinical Fellowship (ACF-2023-19-006)"],"award-info":[{"award-number":["NIHR Academic Clinical Fellowship (ACF-2023-19-006)"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Global Parkinson\u2019s Genetics Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neuropsychiatric symptoms are a significant yet often overlooked aspect of Parkinson\u2019s disease (PD). Using UK Biobank data, we examined associations between neuropsychiatric dimensions and PD risk markers. Factor analysis identified four dimensions\u2014Depression, Anxiety, Adult Stress-Adversity, and Alcohol- and Substance-Related Behaviours (ASRB) \u2014across three groups: PD, healthy controls, and cerebrovascular disease (CVD) as neurological controls. These dimensions showed distinct patterns in PD. Depression scores were significantly elevated, while ASRB scores were consistently lower. Neuroimaging linked ASRB to subcortical changes specific to PD, particularly quantitative susceptibility mapping in the substantia nigra, consistent with the dopaminergic system\u2019s role in goal-directed behaviour.\n                    <jats:italic>GBA1<\/jats:italic>\n                    carrier status was linked to age-related changes in this dimension. Furthermore, PD patients with higher ASRB showed greater volatility in cognitive and motor function, with worsening before diagnosis and subsequent improvement. These findings highlight the complex interplay between psychiatric symptoms, neurobiological changes, and genetic factors in PD, suggesting that specific neuropsychiatric profiles may serve as early indicators of disease risk and progression.\n                  <\/jats:p>","DOI":"10.1038\/s41531-025-01181-y","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:16:29Z","timestamp":1764591389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The relationship between neuropsychiatric dimensions and markers of Parkinson\u2019s disease risk in the UK Biobank"],"prefix":"10.1038","volume":"11","author":[{"given":"Bahaaeddin","family":"Attaallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Noyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"1181_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AH Schapira","year":"2017","unstructured":"Schapira, A. H., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1181_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 5, 235\u2013245 (2006).","journal-title":"Lancet Neurol."},{"key":"1181_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1181_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S. et al. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 34, 1464\u20131470 (2019).","journal-title":"Mov. Disord."},{"key":"1181_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/00019442-200510000-00003","volume":"13","author":"D Weintraub","year":"2005","unstructured":"Weintraub, D. & Stern, M. B. Psychiatric complications in Parkinson disease. Am. J. Geriatr. Psychiatry 13, 844\u2013851 (2005).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1181_CR6","doi-asserted-by":"crossref","unstructured":"Mac\u00edas-Garc\u00eda, P. et al. Neuropsychiatric symptoms in clinically defined Parkinson\u2019s disease: an updated review of literature. Behav. Neurol. 9, 1213393 (2022).","DOI":"10.1155\/2022\/1213393"},{"key":"1181_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2011","unstructured":"Aarsland, D., Pa\u02dahlhagen, S., Ballard, C. G., Ehrt, U. & Svenningsson, P. Depression in Parkinson disease\u2014epidemiology, mechanisms and management. Nat. Rev. Neurol. 8, 35\u201347 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"1181_CR8","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/mds.22589","volume":"24","author":"D Aarsland","year":"2009","unstructured":"Aarsland, D., Marsh, L. & Schrag, A. Neuropsychiatric symptoms in Parkinson\u2019s disease. Mov. Disord. 24, 2175 (2009).","journal-title":"Mov. Disord."},{"key":"1181_CR9","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","volume":"84","author":"H Gustafsson","year":"2015","unstructured":"Gustafsson, H., Nordstro\u00a8m, A. & Nordstro\u00a8m, P. Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology 84, 2422 (2015).","journal-title":"Neurology"},{"key":"1181_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","volume":"16","author":"EL Jacob","year":"2010","unstructured":"Jacob, E. L., Gatto, N. M., Thompson, A., Bordelon, Y. & Ritz, B. Occurrence of depression and anxiety prior to Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 576 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1181_CR11","first-page":"e482","volume":"74","author":"JC Bazo-Alvarez","year":"2024","unstructured":"Bazo-Alvarez, J. C., Nimmons, D., Walters, K., Petersen, I. & Schrag, A. Risk of Parkinson\u2019s disease in people aged 50 years with new-onset anxiety: a retrospective cohort study in UK primary care. Br. J. Gen. Pract. 74, e482 (2024).","journal-title":"Br. J. Gen. Pract."},{"key":"1181_CR12","first-page":"966","volume":"95","author":"JB Badenoch","year":"2024","unstructured":"Badenoch, J. B. et al. Neuroanatomical and prognostic associations of depression in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 95, 966\u2013973 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1181_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0140-6736(14)60041-6","volume":"384","author":"AJ Stoessl","year":"2014","unstructured":"Stoessl, A. J., Lehericy, S. & Strafella, A. P. Imaging insights into basal ganglia function, Parkinson\u2019s disease, and dystonia. Lancet 384, 532\u2013544 (2014).","journal-title":"Lancet"},{"key":"1181_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","volume":"124","author":"B Heim","year":"2017","unstructured":"Heim, B., Krismer, F., De Marzi, R. & Seppi, K. Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease. J. Neural Transm. 124, 915\u2013964 (2017).","journal-title":"J. Neural Transm."},{"key":"1181_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1756285613511507","volume":"7","author":"N Pyatigorskaya","year":"2014","unstructured":"Pyatigorskaya, N., Gallea, C., Garcia-Lorenzo, D., Vidailhet, M. & Lehericy, S. A review of the use of magnetic resonance imaging in Parkinson\u2019s disease. Ther. Adv. Neurol. Disord. 7, 206\u2013220 (2014).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1181_CR16","doi-asserted-by":"crossref","unstructured":"Weintraub, D. et al. The neuropsychiatry of Parkinson\u2019s disease: advances and challenges. Lancet Neurol. 21, 89 (2022).","DOI":"10.1016\/S1474-4422(21)00330-6"},{"key":"1181_CR17","doi-asserted-by":"crossref","unstructured":"Haber, S. N. \u201cAnatomy and connectivity of the reward circuit,\u201d In Decision Neuroscience: An Integrative Perspective, pp. 3\u201319, Elsevier Inc. (2017).","DOI":"10.1016\/B978-0-12-805308-9.00001-4"},{"key":"1181_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41583-018-0029-9","volume":"19","author":"M Husain","year":"2018","unstructured":"Husain, M. & Roiser, J. P. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat. Rev. Neurosci. 19, 470\u2013484 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"1181_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.psc.2009.05.004","volume":"32","author":"EI Martin","year":"2009","unstructured":"Martin, E. I., Ressler, K. J., Binder, E. & Nemeroff, C. B. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr. Clin. North Am. 32, 549 (2009).","journal-title":"Psychiatr. Clin. North Am."},{"key":"1181_CR20","doi-asserted-by":"publisher","first-page":"102634","DOI":"10.1016\/j.nicl.2021.102634","volume":"30","author":"LD Vanes","year":"2021","unstructured":"Vanes, L. D. & Dolan, R. J. Transdiagnostic neuroimaging markers of psychiatric risk: a narrative review. NeuroImage: Clin. 30, 102634 (2021).","journal-title":"NeuroImage: Clin."},{"key":"1181_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","volume":"72","author":"M Goodkind","year":"2015","unstructured":"Goodkind, M. et al. Identification of a common neurobiological substrate for mental illness. JAMA psychiatry 72, 305 (2015).","journal-title":"JAMA psychiatry"},{"key":"1181_CR22","first-page":"8","volume":"5","author":"H Iwaki","year":"2019","unstructured":"Iwaki, H. et al. Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts. Neurol.: Genet. 5, 8 (2019).","journal-title":"Neurol.: Genet."},{"key":"1181_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ene.14115","volume":"27","author":"R Piredda","year":"2020","unstructured":"Piredda, R., Desmarais, P., Masellis, M. & Gasca-Salas, C. Cognitive and psychiatric symptoms in genetically determined Parkinson\u2019s disease: a systematic review. Eur. J. Neurol. 27, 229\u2013234 (2020).","journal-title":"Eur. J. Neurol."},{"key":"1181_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jns.2016.08.059","volume":"370","author":"M Swan","year":"2016","unstructured":"Swan, M. et al. Neuropsychiatric characteristics of GBA-associated Parkinson disease. J. Neurol. Sci. 370, 63\u201369 (2016).","journal-title":"J. Neurol. Sci."},{"key":"1181_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin, A. C. et al. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol. NeurodeGener. 17, 1\u201326 (2022).","journal-title":"Mol. NeurodeGener."},{"key":"1181_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"1181_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-86483-w","volume":"11","author":"S Jo","year":"2021","unstructured":"Jo, S. et al. The role of APOE in cognitive trajectories and motor decline in Parkinson\u2019s disease. Sci. Rep. 11, 1\u201310 (2021).","journal-title":"Sci. Rep."},{"key":"1181_CR28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.28932","volume":"37","author":"AA Szwedo","year":"2022","unstructured":"Szwedo, A. A. et al. GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study. Mov. Disord. 37, 1016 (2022).","journal-title":"Mov. Disord."},{"key":"1181_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R. & Crichton, R. R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863\u2013873 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"1181_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R. & Zecca, L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13, 1045\u20131060 (2014).","journal-title":"Lancet Neurol."},{"key":"1181_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli, R. et al. Parkinson\u2019s disease is associated with hippocampal atrophy. Mov. Disord. 18, 784\u2013790 (2003).","journal-title":"Mov. Disord."},{"key":"1181_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","volume":"20","author":"N Kandiah","year":"2014","unstructured":"Kandiah, N. et al. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 20, 1203\u20131208 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1181_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jns.2006.05.030","volume":"248","author":"A Schrag","year":"2006","unstructured":"Schrag, A. Quality of life and depression in Parkinson\u2019s disease. J. Neurol. Sci. 248, 151\u2013157 (2006).","journal-title":"J. Neurol. Sci."},{"key":"1181_CR34","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.prdoa.2022.100180","volume":"8","author":"B Lacy","year":"2023","unstructured":"Lacy, B., Piotrowski, H. J., Dewey, R. B. & Husain, M. M. Severity of depressive and motor symptoms impacts quality of life in Parkinson\u2019s disease patients at an academic movement clinic: a cross-sectional study. Clin. Parkinsonism Relat. Disord. 8, 100180 (2023).","journal-title":"Clin. Parkinsonism Relat. Disord."},{"key":"1181_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","volume":"12","author":"A Schrag","year":"2006","unstructured":"Schrag, A., Hovris, A., Morley, D., Quinn, N. & Jahanshahi, M. Caregiver-burden in parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat. Disord. 12, 35\u201341 (2006).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1181_CR36","doi-asserted-by":"publisher","first-page":"101840","DOI":"10.1016\/j.arr.2022.101840","volume":"85","author":"MH Ahmad","year":"2023","unstructured":"Ahmad, M. H., Rizvi, M. A., Ali, M. & Mondal, A. C. Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res. Rev. 85, 101840 (2023).","journal-title":"Ageing Res. Rev."},{"key":"1181_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13034-022-00506-6","volume":"16","author":"A Witt","year":"2022","unstructured":"Witt, A. et al. Validation and standardization of the childhood trauma screener (CTS) in the general population. Child Adolesc. Psychiatry Ment. Health 16, 1\u201312 (2022).","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"1181_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jamapsychiatry.2024.0818","volume":"81","author":"JR Baldwin","year":"2024","unstructured":"Baldwin, J. R., Coleman, O., Francis, E. R. & Danese, A. Prospective and retrospective measures of child maltreatment and their association with psychopathology: a systematic review and meta-analysis. JAMA Psychiatry 81, 769\u2013781 (2024).","journal-title":"JAMA Psychiatry"},{"key":"1181_CR39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1176\/appi.ajp.162.3.560","volume":"162","author":"M Oquendo","year":"2005","unstructured":"Oquendo, M. et al. Posttraumatic stress disorder comorbid with major depression: factors mediating the association with suicidal behavior. Am. J. Psychiatry 162, 560\u2013566 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"1181_CR40","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/mds.25863","volume":"29","author":"D Zhang","year":"2014","unstructured":"Zhang, D., Jiang, H. & Xie, J. Alcohol intake and risk of Parkinson\u2019s disease: a metaanalysis of observational studies. Mov. Disord. 29, 819\u2013822 (2014).","journal-title":"Mov. Disord."},{"key":"1181_CR41","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00415-018-9032-3","volume":"266","author":"FJ Jime\u00b4nez-Jime\u00b4nez","year":"2019","unstructured":"Jime\u00b4nez-Jime\u00b4nez, F. J., Alonso-Navarro, H., Garc\u00b4\u0131a-Mart\u00b4\u0131n, E. & Agu\u00b4ndez, J. A. Alcohol consumption and risk for Parkinson\u2019s disease: a systematic review and meta-analysis. J. Neurol. 266, 1821\u20131834 (2019).","journal-title":"J. Neurol."},{"key":"1181_CR42","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3233\/JPD-223522","volume":"12","author":"E Mitchell","year":"2022","unstructured":"Mitchell, E., Chohan, H., Bestwick, J. P. & Noyce, A. J. Alcohol and Parkinson\u2019s disease: a systematic review and meta-analysis. J. Parkinson\u2019s. Dis. 12, 2369\u20132381 (2022).","journal-title":"J. Parkinson\u2019s. Dis."},{"key":"1181_CR43","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/mds.28039","volume":"35","author":"S Peters","year":"2020","unstructured":"Peters, S. et al. Alcohol consumption and risk of Parkinson\u2019s disease: data from a large prospective European cohort. Mov. Disord. 35, 1258\u20131263 (2020).","journal-title":"Mov. Disord."},{"key":"1181_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub, D. et al. Impulse control disorders in parkinson disease: a cross-sectional study of 3090 Patients. Arch. Neurol. 67, 589\u201359 (2010).","journal-title":"Arch. Neurol."},{"key":"1181_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","volume":"24","author":"V Voon","year":"2011","unstructured":"Voon, V., Mehta, A. R. & Hallett, M. Impulse control disorders in Parkinson\u2019s disease: recent advances. Curr. Opin. Neurol. 24, 324\u2013330 (2011).","journal-title":"Curr. Opin. Neurol."},{"key":"1181_CR46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub, D. et al. Validation of the questionnaire for impulsivecompulsive disorders in Parkinson\u2019s disease. Mov. Disord. 24, 1461\u20131467 (2009).","journal-title":"Mov. Disord."},{"key":"1181_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub, D. et al. Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale. Mov. Disord. 27, 242\u2013247 (2012).","journal-title":"Mov. Disord."},{"key":"1181_CR48","doi-asserted-by":"publisher","first-page":"e0217700","DOI":"10.1371\/journal.pone.0217700","volume":"14","author":"VA Izzo","year":"2019","unstructured":"Izzo, V. A., Donati, M. A., Ramat, S. & Primi, C. Impulse control disorders in Parkinson\u2019s disease: a systematic review on the psychometric properties of the existing measures. PLOS One 14, e0217700 (2019).","journal-title":"PLOS One"},{"key":"1181_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ene.12646","volume":"22","author":"H Baumann-Vogel","year":"2015","unstructured":"Baumann-Vogel, H., Valko, P. O., Eisele, G. & Baumann, C. R. Impulse control disorders in Parkinson\u2019s disease: don\u2019t set your mind at rest by self-assessments. Eur. J. Neurol. 22, 603\u2013609 (2015).","journal-title":"Eur. J. Neurol."},{"key":"1181_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1146\/annurev-clinpsy-032813-153705","volume":"10","author":"BB Averbeck","year":"2013","unstructured":"Averbeck, B. B., O\u2019Sullivan, S. S. & Djamshidian, A. Impulsive and compulsive behaviours in Parkinson\u2019s disease. Annu. Rev. Clin. Psychol. 10, 553 (2013).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"1181_CR51","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/mds.25050","volume":"27","author":"N Palacios","year":"2012","unstructured":"Palacios, N. et al. Alcohol and risk of parkinson disease in a large prospective cohort of men and women. Mov. Disord. 27, 980 (2012).","journal-title":"Mov. Disord."},{"key":"1181_CR52","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/brain\/awp094","volume":"132","author":"N B\u00f3di","year":"2009","unstructured":"B\u00f3di, N. et al. Reward-learning and the novelty-seeking personality: a betweenand within-subjects study of the effects of dopamine agonists on young Parkinson\u2019s patients. Brain 132, 2385\u20132395 (2009).","journal-title":"Brain"},{"key":"1181_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neuron.2009.01.031","volume":"61","author":"A Dagher","year":"2009","unstructured":"Dagher, A. & Robbins, T. W. Personality, addiction, dopamine: insights from Parkinson\u2019s disease. Neuron 61, 502\u2013510 (2009).","journal-title":"Neuron"},{"key":"1181_CR54","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/cells12121599","volume":"12","author":"M Be\u00b4reau","year":"2023","unstructured":"Be\u00b4reau, M. et al. Apathy in Parkinson\u2019s disease: clinical patterns and neurobiological basis. Cells 12, 1599 (2023).","journal-title":"Cells"},{"key":"1181_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/jnp.12013","volume":"7","author":"N Sinha","year":"2013","unstructured":"Sinha, N., Manohar, S. & Husain, M. Impulsivity and apathy in Parkinson\u2019s disease. J. Neuropsychol. 7, 255\u2013283 (2013).","journal-title":"J. Neuropsychol."},{"key":"1181_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84364-w","volume":"11","author":"P Petitet","year":"2021","unstructured":"Petitet, P. et al. The relationship between apathy and impulsivity in large population samples. Sci. Rep. 11, 4830 (2021).","journal-title":"Sci. Rep."},{"key":"1181_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-25882-z","volume":"12","author":"P Petitet","year":"2022","unstructured":"Petitet, P., Zhao, S., Drew, D., Manohar, S. G. & Husain, M. Dissociable behavioural signatures of co-existing impulsivity and apathy in decision-making. Sci. Rep. 12, 1\u201312 (2022).","journal-title":"Sci. Rep."},{"key":"1181_CR58","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1007\/s00415-024-12233-3","volume":"271","author":"G Maggi","year":"2024","unstructured":"Maggi, G., Loayza, F., Vitale, C., Santangelo, G. & Obeso, I. Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson\u2019s disease. J. Neurol., 271, 2798\u20132809 (2024).","journal-title":"J. Neurol.,"},{"key":"1181_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jnp.12028","volume":"7","author":"G Dirnberger","year":"2013","unstructured":"Dirnberger, G. & Jahanshahi, M. Executive dysfunction in Parkinson\u2019s disease: a review. J. Neuropsychol. 7, 193\u2013224 (2013).","journal-title":"J. Neuropsychol."},{"key":"1181_CR60","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1073\/pnas.93.9.3908","volume":"93","author":"YI Sheline","year":"1996","unstructured":"Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G. & Vannier, M. W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. 93, 3908\u20133913 (1996).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1181_CR61","first-page":"1","volume":"0","author":"A Paris","year":"2025","unstructured":"Paris, A. et al. Depression and dementia: interrogating the causality of the relationship. J. Neurol. Neurosurg. Psychiatry 0, 1\u20131 (2025).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1181_CR62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/brain\/awz350","volume":"143","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat, C. et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson\u2019s disease and Lewy body dementia. Brain 143, 234 (2019).","journal-title":"Brain"},{"key":"1181_CR63","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. 90, 1977\u20131981 (1993).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1181_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jocn.2022.06.017","volume":"102","author":"F Nabizadeh","year":"2022","unstructured":"Nabizadeh, F., Seyedalhosseini, Z., Balabandian, M. & Reza Rostami, M. Psychological outcomes of the COVID-19 pandemic in patients with Parkinson\u2019s disease: a systematic review. J. Clin. Neurosci. 102, 101 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"1181_CR65","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry, A. et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am. J. Epidemiol. 186, 1026 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"1181_CR66","first-page":"2","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty, G. D., Gale, C. R., Kivima\u00a8ki, M., Deary, I. J. & Bell, S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant metaanalysis. BMJ 368, 2 (2020).","journal-title":"BMJ"},{"key":"1181_CR67","doi-asserted-by":"publisher","first-page":"1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, 1001779 (2015).","journal-title":"PLoS Med."},{"key":"1181_CR68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","volume":"166","author":"F Alfaro-Almagro","year":"2018","unstructured":"Alfaro-Almagro, F. et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. NeuroImage 166, 400\u2013424 (2018).","journal-title":"NeuroImage"},{"key":"1181_CR69","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41593-022-01074-w","volume":"25","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging. Nat. Neurosci. 25, 818\u2013831 (2022).","journal-title":"Nat. Neurosci."},{"key":"1181_CR70","doi-asserted-by":"publisher","first-page":"120068","DOI":"10.1016\/j.neuroimage.2023.120068","volume":"273","author":"PM Cogswell","year":"2023","unstructured":"Cogswell, P. M. & Fan, A. P. Multimodal comparisons of QSM and PET in neurodegeneration and aging. NeuroImage 273, 120068 (2023).","journal-title":"NeuroImage"},{"key":"1181_CR71","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/brain\/awab084","volume":"144","author":"GE Thomas","year":"2021","unstructured":"Thomas, G. E. et al. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson\u2019s disease. Brain 144, 1787\u20131798 (2021).","journal-title":"Brain"},{"key":"1181_CR72","doi-asserted-by":"publisher","first-page":"618435","DOI":"10.3389\/fnins.2021.618435","volume":"15","author":"P Ravanfar","year":"2021","unstructured":"Ravanfar, P. et al. Systematic review: quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases. Front. Neurosci. 15, 618435 (2021).","journal-title":"Front. Neurosci."},{"key":"1181_CR73","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41531-024-00825-9","volume":"10","author":"MA Laansma","year":"2024","unstructured":"Laansma, M. A. et al. A worldwide study of subcortical shape as a marker for clinical staging in Parkinson\u2019s disease. NPJ Parkinson\u2019s. Dis. 10, 223 (2024).","journal-title":"NPJ Parkinson\u2019s. Dis."},{"key":"1181_CR74","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mds.23453","volume":"26","author":"S Tinaz","year":"2010","unstructured":"Tinaz, S., Courtney, M. G. & Stern, C. E. Focal cortical and subcortical atrophy in early Parkinson\u2019s Disease. Mov. Disord. 26, 436 (2010).","journal-title":"Mov. Disord."},{"key":"1181_CR75","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parkreldis.2014.03.009","volume":"20","author":"HM Lee","year":"2014","unstructured":"Lee, H. M. et al. Subcortical grey matter changes in untreated, early stage Parkinson\u2019s disease without dementia. Parkinsonism Relat. Disord. 20, 622\u2013626 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1181_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12868-019-0505-9","volume":"20","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Iron deposition in Parkinson\u2019s disease by quantitative susceptibility mapping. BMC Neurosci. 20, 1\u20138 (2019).","journal-title":"BMC Neurosci."},{"key":"1181_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03123-3","volume":"5","author":"XY Tai","year":"2022","unstructured":"Tai, X. Y., Chen, C., Manohar, S. & Husain, M. Impact of sleep duration on executive function and brain structure. Commun. Biol. 5, 1\u201310 (2022).","journal-title":"Commun. Biol."},{"key":"1181_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18201-5","volume":"11","author":"M Veldsman","year":"2020","unstructured":"Veldsman, M. et al. Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing. Nat. Commun. 11, 1\u201310 (2020).","journal-title":"Nat. Commun."},{"key":"1181_CR79","doi-asserted-by":"publisher","first-page":"e0231627","DOI":"10.1371\/journal.pone.0231627","volume":"15","author":"C Fawns-Ritchie","year":"2020","unstructured":"Fawns-Ritchie, C. & Deary, I. J. Reliability and validity of the UK Biobank cognitive tests. PLoS ONE 15, e0231627 (2020).","journal-title":"PLoS ONE"},{"key":"1181_CR80","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.nicl.2019.101904","volume":"23","author":"L Nobis","year":"2019","unstructured":"Nobis, L. et al. Hippocampal volume across age: nomograms derived from over 19,700 people in UK Biobank. NeuroImage Clin. 23, 101904 (2019).","journal-title":"NeuroImage Clin."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01181-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:03:06Z","timestamp":1764594186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01181-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01181-y","relation":{},"ISSN":["2373-8057"],"issn-type":[{"type":"electronic","value":"2373-8057"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}